The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent

Biomaterials

Volumn 34, Issue 6, 2013, Pages 1635-1643

  Yang, Jing ^a   Zeng, Yong ^b   Zhang, Chao ^a   Chen, Yong Xia ^a   Yang, Ziying ^a   Li, Yongjun ^b   Leng, Xigang ^a   Kong, Deling ^a   Wei, Xiao Qing ^c   Sun, Hong Fan ^a   Song, Cun Xian ^a  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Coronary stents; Gene and drug delivery; Paclitaxel; Restenosis; VEGF

Indexed keywords

ANTIPROLIFERATIVE EFFECT; CLINICAL APPLICATION; CLINICAL STUDY; CORONARY STENTS; DRUG-ELUTING STENTS; GENE TRANSFECTION; HIGH INCIDENCE; IN-STENT RESTENOSIS; IN-VIVO; INNER CORE; OUTER LAYER; PACLITAXEL; PLGA NANOPARTICLES; REPORTER GENE; RESTENOSIS; SLOW RELEASE; SMOOTH MUSCLE CELL PROLIFERATION; VEGF;

CELL CULTURE; COPOLYMERS; DISEASES; DNA; DRUG DELIVERY; GENES;

STENTS;

NANOPARTICLE; PACLITAXEL; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORONARY STENT; CYTOTOXICITY; DRUG ELUTING STENT; GENETIC TRANSFECTION; IN VIVO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; SWINE;

ANIMALS; CHO CELLS; CORONARY RESTENOSIS; CRICETINAE; CRICETULUS; DRUG-ELUTING STENTS; MICROSCOPY, ELECTRON, SCANNING; PACLITAXEL; SWINE; SWINE, MINIATURE; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870778944     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.006     Document Type: Article

References (31)

1. Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987, 316:701-706.
2. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994, 331:489-495.
3. Abizaid A., Kornowski R., Mintz G.S., Hong M.K., Abizaid A.S., Mehran R., et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998, 32:584-589.
4. Alfonso F., Perez-Vizcayno M.J., Cruz A., Garcia J., Jimenez-Quevedo P., Escaned J., et al. Treatment of patients with in-stent restenosis. EuroIntervention 2009, 5:D70-D78.
5. Mauri L., Silbaugh T.S., Garg P., Wolf R.E., Zelevinsky K., Lovett A., et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008, 359:1330-1342.
6. Witkowski A., Opolski M.P., Dudek D., Lesiak M., Legutko J., Wojakowski W., et al. Current status of drug-eluting stents and drug-eluting balloons in patients with stable coronary artery disease-an expert consensus document of the Association for Percutaneous Cardiovascular Interventions and Polish Cardiac Society. Kardiol Pol 2011, 69:1-38.
7. Inoue T., Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009, 73:615-621.
8. Hiltunen M.O., Laitinen M., Turunen M.P., Jeltsch M., Hartikainen J., Rissanen T.T., et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 2000, 102:2262-2268.
9. Ertaş G., Beusekom H.V. Drug eluting stents: current status and new developments. Anadolu Kardiyol Derg 2012, 10.5152/akd.2012.220.
10. Aoki J., Serruys P.W., van Beusekom H., Ong A.T., McFadden E.P., Sianos G., et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the healing-FIM (Healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry. J Am Coll Cardiol 2005, 45:1574-1579.
11. van Beusekom H.M., Ertaş G., Sorop O., Serruys P.W., van der Giessen W.J. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv 2012, 79:231-242.
12. Lee J.M., Choe W., Kim B.K., Seo W.W., Lim W.H., Kang C.K., et al. Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin. Biomaterials 2012, 33:8917-8927.
13. Swanson N., Hogrefe K., Javed Q., Gershlick A.H. In vitro evaluation of vascular endothelial growth factor (VEGF)-eluting stents. Int J Cardiol 2003, 92:247-251.
14. Lahtinen M., Blomberg P., Baliulis G., Carlsson F., Khamis H., Zemgulis V. In vivo h-VEGF165 gene transfer improves early endothelialisation and patency in synthetic vascular grafts. Eur J Cardiothorac Surg 2007, 31:383-390.
15. Walter D.H., Cejna M., Diaz-Sandoval L., Willis S., Kirkwood L., Stratford P.W., et al. Local gene transfer of phvegf-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004, 110:36-45.
16. Yang J., Song C., Sun H., Wu L., Tang L., Leng X., et al. Polymeric nanoparticles with therapeutic gene for gene therapy: I. Preparation and in vivo gene transfer study. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2005, 22:438-442.
17. Yang J., Zeng Y., Li Y., Song C., Zhu W., Guan H., et al. Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis. Eur J Pharm Sci 2008, 35:427-434.
18. Steinbach J.M., Weller C.E., Booth C.J., Saltzman W.M. Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection. J Control Release 2012, 162:102-110.
19. Jensen D.K., Jensen L.B., Koocheki S., Bengtson L., Cun D., Nielsen H.M., et al. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release 2012, 157:141-148.
20. Park S., Bhang S.H., La W.G., Seo J., Kim B.S., Char K. Dual roles of hyaluronic acids in multilayer films capturing nanocarriers for drug-eluting coatings. Biomaterials 2012, 33:5468-5477.
21. Chorny M., Fishbein I., Yellen B.B., Alferiev I.S., Bakay M., Ganta S., et al. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc Natl Acad Sci U S A 2010, 107:8346-8351.
22. Zhu D., Jin X., Leng X., Wang H., Bao J., Liu W., et al. Local gene delivery via endovascular stents coated with dodecylated chitosan-plasmid DNA nanoparticles. Int J Nanomedicine 2010, 5:1095-1102.
23. Yang J., Miao L.F., Zhu W.L., Song C.X. Preparation and biodistribution of paclitaxel-loaded nanoparticles after intravascular infusion. Int J Biomed Eng 2011, 2:70-73.
24. Douglas G., Van Kampen E., Hale A.B., McNeill E., Patel J., Crabtree M.J., et al. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification. Eur Heart J 2012 Sep 24, [Epub ahead of print].
25. Liistro F., Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001, 86:262-264.
26. Otsuka F., Finn A.V., Yazdani S.K., Nakano M., Kolodgie F.D., Virmani R. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol 2012, 9:439-453.
27. Tang C., Wang G., Wu X., Li Z., Shen Y., Lee J.C., et al. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents. J Vasc Surg 2011, 53:461-471.
28. Vanhoutte P.M. Regeneration of the endothelium in vascular injury. Cardiovasc Drugs Ther 2010, 24:299-303.
29. Banning A.P., Groves P.H., Buttery L.D., Wharton J., Rutherford R.A., Black P., et al. Reciprocal changes in endothelial and inducible nitric oxide synthase expression following carotid angioplasty in the pig. Atherosclerosis 1999, 145:17-32.
30. Li H., Zhang L.J., Chen B.H., Zhou X., Su K., Shi W.T., et al. Inhibitory effect of paclitaxel on endothelial cell adhesion and migration. Pharmacology 2010, 85:136-145.
31. Pendyala L., Jabara R., Shinke T., Chronos N., Robinson K., Li J., et al. Drug-eluting stents: present and future. Cardiovasc Hematol Agents Med Chem 2008, 6:105-115.